Not applicableUnknownNCT05023668What this trial is testingChina Atopic Dermatitis Registry StudyWho this might be right forDermatitis, Atopic Peking University People's Hospital 10,000
Large-scale testing (Phase 3)Study completedNCT03428100What this trial is testingA Long-term Study of Baricitinib (LY3009104) With Topical Corticosteroids in Adults With Moderate to Severe Atopic Dermatitis That Are Not Controlled With Cyclosporine or for Those Who Cannot Take Oral Cyclosporine Because it is Not Medically AdvisableWho this might be right forAtopic Dermatitis Eli Lilly and Company 463
Post-approval studies (Phase 4)WithdrawnNCT07187089What this trial is testingStudy of Growth and Bone Mineral Density in Children With Atopic Dermatitis (AD) Treated With DupilumabWho this might be right forSevere Atopic Dermatitis (AD) Regeneron Pharmaceuticals
Not applicableAvailableNCT05466578What this trial is testingPre-approval Single-patient Expanded Access for Abrocitinib (PF-04965842)Who this might be right forSevere Uncontrolled Atopic Dermatitis Pfizer
Large-scale testing (Phase 3)Study completedNCT02755649What this trial is testingAssess the Efficacy and Safety of Dupilumab in Participants With Severe Atopic Dermatitis (AD) That Are Not Controlled With Oral Cyclosporine A (CSA) or for Those Who Cannot Take Oral CSA Because it is Not Medically AdvisableWho this might be right forAtopic Dermatitis Regeneron Pharmaceuticals 325